Icona Azienda

Contract Manufacturing

Contract Manufacturing

Alfasigma is a leading company in Contract Manufacturing, able to provide an integrated and exhaustive service covering all aspects of this activity, and to be a unique partner in outsourcing activities for the manufacturing of nearly all pharmaceutical forms, in the volumes required, for outside bodies.

High qualitative standards and the utmost reliability are always ensured, thanks to the know-how obtained in many years' experience, the use of innovative technologies and a modern plant, which has been recently enlarged and further developed.
 

Alanno
Plant


Via Enrico Fermi, 1
65020 Alanno
(Pescara)
Italy

Stabilimento di Alanno

The Alanno plant is located close to Pescara, in Italy's Abruzzo region, on a site of 100,000 square metres. To rationalise space and maximise efficiency by streamlining workflows, the plant is divided into 11 departments housed In 7 bulidings. This high-technology pharmaceutical plant is now undergoing further expansion following the addition in 2017 of two new sterile departments, one of which boosted production of pre-filled syringes and cartridges to more than 150 million units per year, while the other was specifically designed for sterile powders, with high-performance equipment for filling vials. The expansion currently under way involves both production departments and offices and laboratories.

 

Pomezia
Plant


Via Pontina,
Km 30,400
00071 Pomezia
(Roma)
Italy

Stabilimento di Pomezia

Pomezia plant has been recently acquired, becoming part of Alfasigma Contract Manufacturing footprint. Located in Lazio, near Rome, the site has an overall surface area of 344,000 m2 divided in three main areas: Manufacturing and Laboratories, Warehousing, Utilities and Services. Production is focused on four different formulations: oral solids, including granules, tablets, film-coated tablets and hard gelatin capsules; oral liquids, including drops and syrups; semisolids; injectables. The plant is able to meet any need of leading pharmaceutical companies thanks to its capacity, currently reaching 80 million units manufactured and packaged every year.